LENZ Therapeutics, Inc. - LENZ
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Investments L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Investments LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Management LLC | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 11.8% | 3,702,718 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.8% | 3,702,718 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.9% | 1,537,723 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 3.8% | 1,073,461 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 3.8% | 1,073,461 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 3.8% | 1,073,461 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 3.3% | 946,447 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 1.2% | 340,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 1.2% | 340,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Biotech Private Investments, LLC | 3.6% | 1,017,751 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Differentiated Ventures Investments, LLC | 3.6% | 1,017,751 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | 72 Investment Holdings, LLC | 3.6% | 1,017,751 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven A. Cohen | 4.8% | 1,357,751 | View |
| Nov 10, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 07, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 07, 2025 | SCHEDULE 13G | FMR LLC | 15.0% | 4,278,244 | View |
| Nov 07, 2025 | SCHEDULE 13G | Abigail P. Johnson | 15.0% | 4,278,244 | View |
| Oct 17, 2025 | SCHEDULE 13G | BlackRock, Inc. | 5.1% | 1,442,864 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.